Cannabis-Mental Health Link Has Doubled in Strength Since 2012 in Canada
The associations between cannabis use and anxiety, depression, and suicidality roughly doubled in strength from 2012 to 2022 in Canada, with frequent users showing up to 5.4 times higher prevalence of suicidality by 2022.
Quick Facts
What This Study Found
From 2012 to 2022, the prevalence ratio for weekly+ cannabis use (vs. no use) increased from 2.3 to 4.5 for generalized anxiety disorder, 3.0 to 5.2 for major depression, and 3.0 to 5.4 for suicidality — with strengthening associations particularly among youth and females for certain outcomes.
Key Numbers
N=34,974 across 2 surveys; GAD PR: 2.3→4.5; MDE PR: 3.0→5.2; suicidality PR: 3.0→5.4 for weekly+ users; prevalence of GAD, MDE, and cannabis use approximately doubled from 2012-2022; youth suicidality up 44%
How They Did This
Comparison of two nationally representative Canadian cross-sectional surveys — CCHS-MH 2012 (n=25,113) and MHACS 2022 (n=9,861) — using Robust Poisson Regression to examine frequency-dependent associations between cannabis use and WHO-CIDI-diagnosed GAD, MDE, and suicidality.
Why This Research Matters
Both cannabis use and mental health problems have increased in Canada, but this study reveals that their association has also strengthened — meaning the mental health burden linked to cannabis may be growing faster than either trend alone would suggest.
The Bigger Picture
In the post-legalization and post-pandemic era, the strengthening cannabis-mental health association demands urgent attention — particularly the dose-response relationship showing risks increase with frequency of use.
What This Study Doesn't Tell Us
Cross-sectional surveys cannot establish causality; 2022 data collected during pandemic aftermath may inflate mental health prevalence; potential confounding despite adjustment; diagnostic interview differences between surveys possible; cannot determine directionality.
Questions This Raises
- ?Is the strengthening association driven by higher-potency products, more frequent use, or greater vulnerability in a post-pandemic population?
- ?Would longitudinal data confirm cannabis causing more mental health problems?
- ?Are treatment services keeping pace?
Trust & Context
- Key Stat:
- Evidence Grade:
- Two large nationally representative surveys with validated diagnostic instruments provide strong ecological evidence, though cross-sectional design limits causal inference.
- Study Age:
- Published 2026; compares 2012 (pre-legalization) to 2022 (post-legalization and post-pandemic).
- Original Title:
- Changes in Cross-Sectional Associations Between Cannabis Use and Anxiety, Depression, and Suicidality in a Nationally Representative Sample of Canadians From 2012 to 2022: Évolution des relations transversales entre la consommation de cannabis et la dépression, l'anxiété et les idées suicidaires au sein d'un échantillon représentatif de Canadiens à l'échelle nationale, de 2012 à 2022.
- Published In:
- Canadian journal of psychiatry. Revue canadienne de psychiatrie, 7067437261420701 (2026)
- Authors:
- Halladay, Jillian(6), Ji, Chris, Georgiades, Katholiki(3), McDonald, André, Sunderland, Matthew, Slade, Tim, Chapman, Cath, MacKillop, James
- Database ID:
- RTHC-08308
Evidence Hierarchy
A snapshot of a population at one point in time.
What do these levels mean? →Frequently Asked Questions
Is the link between cannabis and mental health getting stronger?
In Canada, yes — from 2012 to 2022, the association between frequent cannabis use and anxiety, depression, and suicidality roughly doubled in strength, even after accounting for rising rates of both cannabis use and mental health problems.
Does cannabis use frequency matter for mental health risk?
Yes — this study found a clear dose-response pattern: the more frequently someone used cannabis, the stronger the association with anxiety, depression, and suicidality, with weekly+ use showing the strongest links.
Read More on RethinkTHC
Cite This Study
https://rethinkthc.com/research/RTHC-08308APA
Halladay, Jillian; Ji, Chris; Georgiades, Katholiki; McDonald, André; Sunderland, Matthew; Slade, Tim; Chapman, Cath; MacKillop, James. (2026). Changes in Cross-Sectional Associations Between Cannabis Use and Anxiety, Depression, and Suicidality in a Nationally Representative Sample of Canadians From 2012 to 2022: Évolution des relations transversales entre la consommation de cannabis et la dépression, l'anxiété et les idées suicidaires au sein d'un échantillon représentatif de Canadiens à l'échelle nationale, de 2012 à 2022.. Canadian journal of psychiatry. Revue canadienne de psychiatrie, 7067437261420701. https://doi.org/10.1177/07067437261420701
MLA
Halladay, Jillian, et al. "Changes in Cross-Sectional Associations Between Cannabis Use and Anxiety, Depression, and Suicidality in a Nationally Representative Sample of Canadians From 2012 to 2022: Évolution des relations transversales entre la consommation de cannabis et la dépression, l'anxiété et les idées suicidaires au sein d'un échantillon représentatif de Canadiens à l'échelle nationale, de 2012 à 2022.." Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2026. https://doi.org/10.1177/07067437261420701
RethinkTHC
RethinkTHC Research Database. "Changes in Cross-Sectional Associations Between Cannabis Use..." RTHC-08308. Retrieved from https://rethinkthc.com/research/halladay-2026-changes-in-crosssectional-associations
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.